Brief: Biosynex Takes 75% Stake In Danish Firm Medkoncept
21/12/2022 17:11
Dec 21 (Reuters) - Biosynex SA ALBIO.PA :
* TAKES STAKE OF 75% IN DANISH FIRM MEDKONCEPT AS
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals